Navigation Links
CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression of Rheumatoid Arthritis
Date:2/22/2010

reatments comprise an approximately $13 billion market.  Enbrel, a leading rheumatoid arthritis treatment sold by Amgen and Wyeth, reported US sales in 2007 of about $3.2 billion.  Enbrel is a soluble recombinant protein of a human TNF-alpha receptor linked to human IgG Fc.  In some cases, human or humanized monoclonal antibodies specific against TNF-alpha have also been used for therapy in rheumatoid arthritis.  These therapies remove or inactivate TNF-alpha, a natural human cytokine required in many immune functions for normal defenses.  

CEL-SCI's rheumatoid arthritis vaccine CEL-2000 was discovered as part of work with the Company's ongoing research and development activities with its L.E.A.P.S.™ (Ligand Epitope Antigen Presentation System) technology.  L.E.A.P.S. is a novel T-cell modulation platform technology that enables CEL-SCI to design and synthesize proprietary immunogens. Any disease for which an antigenic sequence has been identified, such as infectious, parasitic, malignant or autoimmune diseases and allergies, are potential therapeutic or preventive sites for the application of L.E.A.P.S. technology.

The concept behind the L.E.A.P.S. technology is to directly mimic cell-cell interactions and activate immune cells with synthetic peptides. The L.E.A.P.S. constructs containing the antigenic disease epitope linked to a immune-cell binding ligand (ICBL) can be manufactured by peptide synthesis or by covalently linking the two peptides. Depending
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CEL-SCI Corporation Releases Letter to Shareholders
2. CEL-SCI Corporation Reports First Quarter 2010 Financial Results
3. CEL-SCI to Present at 12th Annual BIO CEO & Investor Conference
4. CEL-SCI Hires Vice President of Manufacturing/Facilities and Commercial Operations
5. CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine
6. CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine
7. CEL-SCI Corporation Releases Letter to Shareholders
8. CEL-SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1-Infected Patients
9. CEL-SCI Expands H1N1 Flu Virus Work
10. CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series
11. CEL-SCI Posts New Corporate Presentation to Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... and HERZLIYA PITUACH, Israel , ... (NASDAQ: IMNP ) announced today that its Board ... Board succeeding Dr. Daniel Teper who continues as ... member of Immune,s Board of Directors since 2013. ... am delighted to represent the interest of shareholders and to ...
(Date:12/15/2014)... LONDON , December 15, 2014 ... (NASDAQ: ZGNX ), Eli Lilly and Company (NYSE: ... ), Sanofi (NYSE: SNY ), and Novartis AG ... companies can be accessed at: http://investor-edge.com/register . ... 4,653.60, down 1.16%, the Dow Jones Industrial Average lost 1.79%, ...
(Date:12/15/2014)... , Dec. 15, 2014  The Government of Ghana ... AABB, Global Blood Fund (GBF) and Terumo BCT to respond to ... as well as provide long-term health system capacity to the citizens ... , The Ghanaian Ebola Readiness and Resilience Initiative (GERRI) is ... preparations for the possible arrival of the Ebola epidemic ...
Breaking Medicine Technology:Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6
... Asthmatx, Inc. presented the results of a series ... thermoplasty delivered by the Alair® System, and how this ... in a poster at the 2009 Annual Meeting of ... in Miami Beach, Fla. , The poster, titled "Where ...
... PALO ALTO, Calif., Nov. 9 Women,s sexual health company, ... as it prepares for a 2010 launch of its Viveve ... a name that we believe captures the essence of our ... president and chief executive. "Viveve exists for the sole purpose ...
Cached Medicine Technology:Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3Women's Sexual Health Company Changes Name in Preparation for Market Entry 2
(Date:12/17/2014)... No matter how far modern medicine ... the head louse parasite—a common childhood malady and a ... between six and twelve million individuals will suffer an ... treatment company comes to the rescue, providing an all-natural ... its track record of customer service, and effectiveness in ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Project Veritas ... recently brought videos of MIT economist and Obamacare architect ... author James O’Keefe conducted the interview, which is being ... that there was intentional mislabeling in the Affordable Care ... the bill: A two-hundred-and-fifty billion dollar per year tax ...
(Date:12/17/2014)... Alan Mozes HealthDay ... In the world of infectious diseases, one worrisome phenomenon is ... people. The process -- known as zoonosis -- is ... look for signs that an animal-borne disease might make inroads ... just such a development -- and the culprits in this ...
(Date:12/17/2014)... Dec. 16, 2014 (HealthDay News) -- Poor students get more ... a new study finds. But, the opposite is true ... having fruits and vegetables at school may give a healthy ... But, no matter what the family income level, students all ... the study found. The study was published recently in ...
(Date:12/17/2014)... Alan Mozes HealthDay Reporter ... the holiday party season fast approaching, a new study reveals ... DUI arrests have fewer drunk drivers on their roads. ... more vigilantly are better able to deter inebriated revelers from ... any new laws are being passed regarding drinking and driving," ...
Breaking Medicine News(10 mins):Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Poor Students Eat Healthier Foods at School, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3
... Health Care has been selected to be ... major state roadwork projects.(Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b )Preferred ... steered to Aurora Health Care,s Occupational Health during ... hours."Aurora was the preferred provider for the Marquette ...
... April 8 A nationwide poll conducted on ... surveyed believe it is important to "make sure ... to participate in procedures and practices to which ... company(TM), inc./WomanTrend on behalf of the Christian Medical ...
... evident symptoms of heartburn , , WEDNESDAY, April 8 (HealthDay ... you don,t have heartburn symptoms, too, a new study ... gastroesophageal reflux disease, or GERD. But some people have ... symptoms. , Doctors have suspected that if people with ...
... The Methuselah Foundation, a global nonprofit-organization dedicated ... co-sponsorship of My Bridge 4 Life(TM), a unique ... facing the challenges of a life threatening disease ... who have just been there.Through My Bridge 4 ...
... on April 24 ALEXANDRIA, Va., April 8 On ... CEO, joined an invitation-only meeting at the White House ... of the White House Office of Health Care Reform ... important meeting is an indicator of the commitment of ...
... Fla. and CHICAGO, April 8 The ... QGP ) following the conclusion of the HIMSS09* conference ... IBM ) to facilitate IBM,s Patient Centered Medical ... with a 21st Century process for electronic records integration, ...
Cached Medicine News:Health News:Aurora Chosen as Preferred Provider for Workers on 2 Major State Road Projects 2Health News:New Poll Shows Strong Support for Conscience Rights in Health Care 2Health News:Acid Reducers May Not Help All With Asthma 2Health News:Acid Reducers May Not Help All With Asthma 3Health News:The Methuselah Foundation Co-Sponsors My Bridge 4 Life and Tips 4 Life 2Health News:NHPCO President/CEO Meets with Nancy-Ann Min DeParle at White House 2Health News:Quantum and IBM Align to Drive Medical Home Solution 2Health News:Quantum and IBM Align to Drive Medical Home Solution 3Health News:Quantum and IBM Align to Drive Medical Home Solution 4Health News:Quantum and IBM Align to Drive Medical Home Solution 5Health News:Quantum and IBM Align to Drive Medical Home Solution 6
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: